Clinical trials designed to evaluate the use of anti-cancer drugs for the treatment of cancer typically exclude patients whose disease has spread to the brain or CNS for a number of reasons, including the misperception that they are poor clinical trial candidates.
A sick stomach, to high-fever, chest pains and heart infection is just a learning experience for some doctors.
Why do some pediatric ALL survivors live the rest of their lives cancer-free, while others face secondary cancers or death?
We don’t need to move mountains, build a house or even clean out every closet in one day. Sometimes we just have to clean one shelf at a time, put one foot in front of the other and remind ourselves that is enough for today.
The scars breast cancer leaves on our bodies tell a story. What will yours say?
Today women face a plethora of options. Their tumors are tested for all kinds of differences that may tell them if chemotherapy will work and which drugs would work best. There are support groups and help for families that we didn’t have.
Two-time cancer survivor discusses the art of waiting, be it for treatments, rechecks or test results.
Safety net hospitals exist to offer care to vulnerable populations, such as those on Medicaid or who are uninsured. However, these patients still face barriers to care that affect survival outcomes.
The Food and Drug Administration (FDA) granted priority review to the combination use of Darzalex (daratumumab), Velcade (bortezomib), melphalan and prednisone for the treatment of newly diagnosed patients with multiple myeloma who are not eligible for autologous stem cell transplant (ACST).
Breast cancer survivor speculates about achieving health and wonders what "healthy" even means. Is the game rigged?
It's sometimes easy to think that our bodies have failed us, but we need all the help we can get.
A vast majority of my friends and the people that I know are in the field of nursing. Because of this, the phrase, “just a nurse” isn't one that I hear very often. That being said, I was having a conversation the other day and that sentence set my ears on fire. I was immediately taken aback by the sheer ignorance that I had been privy to.
Gary thought he had emphysema, but ended up preparing to fight for his life.
The third week in January is national Teen Cancer Awareness Week, a time to shine light on the unique medical, emotional and psychosocial needs of teens with cancer. But one organization focuses on these concerns year-round: Teen Cancer America (TCA).
Marina Chiara Garassino, M.D., talks about how immunotherapy agents have vastly improved the treatment field of patients with non-small cell lung cancer.
Breast cancer survivor gives ideas to cope with genetic cancer test results worry.
While the treatment of leukemia has greatly advanced since 1946, so has the organization. In the past seven decades, LRF has raised more than $75 million for its mission of conquering not only leukemia, but all blood cancers.
A major insurer takes a 20-year, first-line standard treatment off its preferred list in one market. But where will it end?
Research constantly highlights how adequate sleep impacts health outcomes. A recent meta-analysis, published in Cancer Epidemiology, Biomarkers & Prevention, delved in a bit further to see if people who stayed up all night for work had an increased chance of developing cancer.
So, wouldn't it be nice to have a quantitative way to say how deep the remission is? Historically, it’s been felt that if you just scratch the surface and get below the 5 percent blast level, you’re probably going to relapse. And if you get deeper, you might not.
Breast cancer survivor shares how she approaches her ongoing chemo brain.
Knowing that my sister gained remission gives me an immense bias, but ask the question, “Good or bad?” now and my answer may just be, “hard to tell.”
Many breast cancer survivors choose to adorn their chests with beautiful designs in an effort to camouflage unsightly scars. Could this practice be dangerous to their health? Read one survivor's viewpoint.
The Food and Drug Administration (FDA) approved a supplemental new drug application that adds overall survival (OS) data from the phase 3 ENDEAVOR trial to the label for Kyprolis (carfilzomib) to treat patients with relapsed or refractory multiple myeloma.
A study, conducted at Penn State College of Medicine, demonstrated that patients with melanoma who received immunotherapy while also taking a specific type of beta blocker lived longer than those who received immunotherapy alone.
Sometimes a kind gesture can mean the world to someone going through a tough time.
Over the past few years, the Food and Drug Administration (FDA) has approved a variety of triplet combinations for the treatment of patients with multiple myeloma. However, little is known which regimens have the best economic impact, without sacrificing clinical outcomes that is.
Some patients refer to this as their cancerversary. With two years in the rear-view mirror, I’m calling it my Everything-From-Here-On-Out-Is-Gravy Day.
The Food and Drug Administration granted a priority review to a supplemental biologics license application for Kymriah (tisagenlecleucel) to be used to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma who either relapse or are not eligible for an autologous stem cell transplant.
The oldest cases of multiple myeloma and breast cancer date back to ancient Egyptian mummies.
